Nature Conference: Innovative Tissue Therapies from Bench to Bedside

Register for #NatconfTissue21, organized by Nature Communications, to hear from an international panel of speakers as they share their latest advancements in tissue engineering, gene therapy, cell therapy, and innovative clinical treatments.
Nature Conference: Innovative Tissue Therapies from Bench to Bedside
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

At an upcoming virtual Nature Conference, Innovative Tissue Therapies from Bench to Bedside, we will hear from scientists developing innovative pre-clinical approaches in the realm of gene therapy, cell therapy and tissue engineering. Similarly, clinical researchers will give their perspective on the application of the most promising innovative treatments in human patients. 

Event Details 
November 16-18, 2021
07:00 EST (New York) | 12:00 GMT (London) | 13:00 CST (Milan) | 20:00 CST (Shanghai)

Presented by: I.R.C.C.S Ospedale San Raffaele and Nature Communications

Register now and be sure to submit your abstract by the September 20th deadline!

Learn more

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology

Related Collections

With Collections, you can get published faster and increase your visibility.

Women's Health

A selection of recent articles that highlight issues relevant to the treatment of neurological and psychiatric disorders in women.

Publishing Model: Hybrid

Deadline: Ongoing

Advances in neurodegenerative diseases

This Collection aims to bring together research from various domains related to neurodegenerative conditions, encompassing novel insights into disease pathophysiology, diagnostics, therapeutic developments, and care strategies. We welcome the submission of all papers relevant to advances in neurodegenerative disease.

Publishing Model: Hybrid

Deadline: Dec 24, 2025